SAH (Subarachnoid Hemorrhage)
Conditions
Keywords
SAH, Cerebrolysin, neuromonitoring
Brief summary
Subarachnoid haemorrhage often affects people in middle age and is associated with high mortality or neurological damage. In recent years, advances in surgical techniques have im-proved the mortality rate. However, there is still need for the research for the optimal possible final effect of treatment. In our study, we've decided to examine the effect of a multimodal approach including Cerebrolysin in the supportive treatment of patients. We've examined the supply of neuroprotective drugs and neuromonitoring.
Interventions
None listed
Sponsors
Pomeranian Medical University Szczecin
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* age \>18 years old, diagnosis of SAH, treatment in ICU conditions
Exclusion criteria
* age \<18 years, medical history of allergy to Cerebrolysin, acute renal failure, pregnancy, multi organ trauma, death within 48 hours after admission
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| GOS Glasgow Outcome Scale | 1 month | Glasgow Outcome Scale - 5 points scale, characterizing the patients' deficits |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| LOS Length of Stay | hospitalisation time | length of stay in days, that patient spent in hospital/ intensive care unit |
| mortality | 1 month | mortality |
Countries
Poland
Outcome results
None listed